Ralf Bartenschlager
Heidelberg University
Germany
EMBL Conference
The COVID-19 pandemic has placed infection research into the spotlight, highlighting once again the complexity and devastating impact that infectious diseases can have. Pathogens do not respect national, ecological or species boundaries. Therefore, efforts to tackle them need to be global, coordinated and interdisciplinary. Science should play a key role in helping to tackle the challenge we face today and prevent future pandemics. This online conference will bring together research experts from different fields to present our current knowledge, strategies and approaches on SARS-CoV-2 biology, epidemiology and anti-infectives, but also to put this knowledge into the context of other infectious diseases, be they of viral, bacterial or eukaryotic origin. The meeting will provide an international forum to discuss current limitations, lessons learned, opportunities and perspectives emerging.
The beginning of the 21st century has provided ample of evidence for the complexity and severity of infectious diseases: from the numerous prior zoonotic-origin viral outbreaks, to the millions of deaths caused yearly by well-known pathogens such as TB, HIV and malaria; and from antimicrobial resistance emerging as one of the most serious public health threats of our time, to vaccination non-compliance bringing back diseases of the past. Coordinated and interdisciplinary research is urgently needed. Using the current SARS-CoV-2 outbreak as a focal point, the meeting aims to initiate a discussion on future directions in infection research, and nucleate new synergies to get us better prepared for the next outbreak.
Heidelberg University
Germany
EMBL-EBI Hinxton
UK
EMBL Grenoble
France
DZIF German Center for Infection Research
Germany
Institut Pasteur
France
German Center for Infection Research
Germany
Imperial College London
UK
Erasmus MC
The Netherlands
Helmholtz Centre for Infection Research
Germany
University of California San Francisco
USA
Max Planck Institute for Infection Biology
Germany
European Commission
Belgium
GlaxoSmithKline Vaccines
Italy
Institut Pasteur
France
Harvard University
USA
Johannes Gutenberg
University Mainz
Germany
Institut Pasteur
France
EPFL
Switzerland
University of Pennsylvania
USA
EMBL-EBI Hinxton
UK
Institut Pasteur
France
Helmholtz Centre for Infection Research
Germany
EMBO
Germany
EMBL Heidelberg
Germany
EMBL Heidelberg
Germany
Date: 3 Jul 2020
Location: Virtual